Surevest’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-53
Closed -$4K 605
2022
Q2
$4K Hold
53
﹤0.01% 367
2022
Q1
$4K Hold
53
﹤0.01% 345
2021
Q4
$5K Buy
+53
New +$5.09K ﹤0.01% 331

Other funds holding SYNH

Surevest's SYNH Position: Q3 2022 in Review

Surevest sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2022, closing a stake of 53 shares — an estimated $4K sold.

Surevest first reported a position in SYNH in Q4 2021 and held it in 3 quarters. The position peaked at $5K in Q4 2021. 337 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.

  • Surevest reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Surevest sold 53 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $4K.
  • Surevest first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 3 quarters.
  • Surevest's Syneos Health, Inc. Class A Common Stock position peaked at $5K in Q4 2021.
  • 337 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.

Based on Surevest's 13F filing for Q3 2022, filed 14 Nov 2022.